TwinStrand Biosciences
Company Details
Status: Private
Employees: 11-50
Location:
3131 elliott avenue, seattle, washington, united states, 98121
Type:
sample
sample
Technology:
sample
sample
About: TwinStrand Biosciences is a biotechnology company that specializes in ultra-sensitive genomic analysis using its proprietary Duplex Sequencing® technology. This innovative approach significantly reduces sequencing error rates, allowing for the detection of ultra-low-frequency genetic variants. This capability is essential for high-precision applications in cancer research, genetic toxicology, and monitoring cellular immunotherapies.
Founded to enhance genomic accuracy, TwinStrand focuses on translating academic innovations into practical solutions for clinical and research environments. The company offers Duplex Sequencing Kits for various applications, including measurable residual disease detection in acute myeloid leukemia and mutation signature analysis. Additionally, it provides proprietary biochemistry and cloud-based informatics tools to identify variants that standard next-generation sequencing cannot detect. TwinStrand is also pursuing regulatory development to enhance decision-making in genetic toxicology. Through collaborations and partnerships, TwinStrand aims to expand the reach of its technology and improve global regulatory standards.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
TwinStrand Biosciences | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.